Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
Go back to Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders| (NASDAQ: CMND) | Delayed: 2.60 -0.08 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.68 | 52 Week High | $ | |||
| Open | $2.64 | 52 Week Low | $ | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $ | |||
| Volume | 19,171 | |||||

